Results 1-10 of 65
Publication DateTitleAuthor(s)
20-Nov-2015Glucagon increases energy expenditure independently of brown adipose tissue activation in humansSalem, V; Izzi-Engbeaya, C; Coello, C; Thomas, DB; Chambers, ES, et al
16-Jan-2009Mice With Hyperghrelinemia Are Hyperphagic and Glucose Intolerant and Have Reduced Leptin SensitivityBewick, GA; Kent, A; Campbell, D; Patterson, M; Ghatei, MA, et al
1-Jul-2009Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balanceSemjonous, NM; Smith, KL; Parkinson, JRC; Gunner, DJL; Liu, Y-L, et al
28-Jul-2016Randomised clinical study: inulin short-chain fatty acid esters for targeted delivery of short-chain fatty acids to the human colon.Polyviou, T; MacDougall, K; Chambers, ES; Viardot, A; Psichas, A, et al
5-Apr-2016Kisspeptin Expression in the Human Infundibular Nucleus in Relation to Sex, Gender Identity, and Sexual OrientationTaziaux, M; Staphorsius, AS; Ghatei, MA; Bloom, SR; Swaab, DF, et al
17-Dec-2015Subcutaneous infusion of kisspeptin-54 stimulates gonadotrophin release in women and the response correlates with basal oestradiol levelsNarayanaswamy, S; Jayasena, CN; Ng, N; Ratnasabapathy, R; Prague, J, et al
11-Aug-2015Arcuate nucleus glucokinase and dietary glucose intakeMa, Y; Bloom, SR; Gardiner, JV
1-Apr-2013Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of HyperglycemiaTan, TM; Field, BCT; McCullough, KA; Troke, RC; Chambers, ES, et al
1-Apr-2008Elevated cocaine- and amphetamine-regulated transcript immunoreactivity in the circulation of patients with neuroendocrine malignancyBech, P; Winstanley, V; Murphy, KG; Sam, AH; Meeran, K, et al
9-Jan-2015Comparison of the Utility of Cocaine- and Amphetamine-Regulated Transcript (CART), Chromogranin A, and Chromogranin B in Neuroendocrine Tumor Diagnosis and Assessment of Disease ProgressionRamachandran, R; Bech, P; Murphy, KG; Caplin, ME; Patel, M, et al